Predicting antipsychotic drug response - Replication and extension to six weeks in an international olanzapine study

Those patients who showed little to no reduction of symptoms at week 2 were unlikely to show even minimal response at weeks 4 to 6. There is increasing evidence that such patients may benefit from a change in treatment.